Healthcare - Biotechnology - NASDAQ - US
$ 25.05
-12 %
$ 3.61 B
Market Cap
-9.08
P/E
CASH FLOW STATEMENT
-358 M
OPERATING CASH FLOW
249 M
INVESTING CASH FLOW
17.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Denali Therapeutics Inc.
| Net Income | -145 M |
| Depreciation & Amortization | 16.7 M |
| Capital Expenditures | -12.9 M |
| Stock-Based Compensation | 108 M |
| Change in Working Capital | -290 M |
| Others | -340 M |
| Free Cash Flow | -371 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (145.2) | (326.0) | (290.6) | 71.1 | (197.6) | (36.2) | (88.2) | (86.7) | (16.8) |
| Depreciation & Amortization | 16.7 | 10.4 | 8.6 | 8.5 | 8.0 | 7.4 | 3.1 | 1.5 | 0.1 |
| Deferred Income Tax | 0 | 0 | 8.7 | 55 K | (5.0) | 0 | 0 | 0.3 | 0 |
| Stock Based Compensation | 108.1 | 99.8 | 85.2 | 50.4 | 38.4 | 18.8 | 4.4 | 3.0 | 0.5 |
| Other Operating Activities | (47.7) | (4.9) | (3.0) | (2.3) | 0.5 | (2.7) | 0.8 | 5.3 | 0.7 |
| Change in Working Capital | (289.9) | (24.0) | (20.4) | 288.4 | 4.2 | 62.9 | 3.3 | 4.3 | 0.4 |
| Cash From Operations | (358.0) | (244.7) | (211.4) | 416.2 | (151.6) | 50.1 | (76.6) | (72.4) | (15.1) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (12.9) | (17.8) | (8.5) | (3.1) | (17.9) | (3.4) | (2.9) | (6.1) | (3.1) |
| Other Items | 262.2 | (123.6) | (13.1) | (620.1) | 165.6 | (284.0) | (38.3) | (212.9) | 0 |
| Cash From Investing Activities | 249.3 | (141.4) | (21.6) | (623.2) | 147.7 | (287.4) | (41.2) | (219.0) | (3.1) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 14.5 | 19.3 | 20.7 | 6.2 | 2.6 | 30.7 | 300.5 | 43.7 |
| Cash From Financing Activities | 17.8 | 310.7 | 19.3 | 634.7 | 6.2 | 97.0 | 296.3 | 300.5 | 48.9 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | (90.9) | (75.4) | (213.7) | 427.7 | 2.3 | (140.3) | 178.5 | 9.1 | 30.7 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (370.9) | (262.5) | (219.9) | 413.1 | (169.5) | 46.7 | (79.5) | (78.5) | (18.1) |